(NASDAQ: AZTA) Azenta's forecast annual revenue growth rate of 5.27% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.
Azenta's revenue in 2025 is $593,821,000.On average, 10 Wall Street analysts forecast AZTA's revenue for 2026 to be $28,849,419,824, with the lowest AZTA revenue forecast at $27,607,058,696, and the highest AZTA revenue forecast at $29,896,317,356. On average, 10 Wall Street analysts forecast AZTA's revenue for 2027 to be $30,296,857,513, with the lowest AZTA revenue forecast at $28,589,412,042, and the highest AZTA revenue forecast at $31,626,650,836.
In 2028, AZTA is forecast to generate $31,700,807,985 in revenue, with the lowest revenue forecast at $29,607,928,442 and the highest revenue forecast at $33,108,420,539.